(Q33881866)

29 July 2017

1 reference

title

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

1

1 reference

29 July 2017

Jørgensen HA

2

1 reference

29 July 2017

publication date

1 August 2000

1 reference

29 July 2017

published in

Progress in Neurobiology

1 reference

29 July 2017

volume

61

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

525-541

1 reference

The functional anatomy of basal ganglia disorders

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The mitochondrial toxin 3-nitropropionic acid induces vacuous chewing movements in rats. Implications for tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The rat model of tardive dyskinesia: Relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Reduced number of striatal neurons expressing preprosomatostatin mRNA in rats with oral dyskinesias after long-term haloperidol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Vitamin E (α-Tocopherol) in the Treatment of Tardive Dyskinesia: A Statistical Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

MRI in tardive dyskinesia: shortened left caudate T2.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Oxidative stress-resistant cells are protected against haloperidol toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neuroleptic medications inhibit complex I of the electron transport chain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The action of chlorpromazine and imipramine on rat brain mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Free radical mechanisms in schizophrenia and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Does dopamine play a role in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Tardive dyskinesia and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Antipsychotic-Induced Tardive Dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Changes in dopamine-mediated behaviour during one year's neuroleptic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Persistent Dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Effectiveness of vitamin E for treatment of long-term tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Excitotoxic Mechanisms May Be Involved in the Pathophysiology of Tardive Dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Extracellular glutamate levels increase with age in the lateral striatum: potential involvement of presynaptic D-2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Treatment of tardive dyskinesia with vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Selective cortical infarction reduces [3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The effect of phenothiazone on the metabolism of liver mitochondria.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Tiagabine inhibits haloperidol-induced oral dyskinesias in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Remodeling of synaptic architecture during hippocampal "kindling"

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Intermittent neuroleptic treatment induces long-lasting abnormal mouthing in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Development of vacuous chewing movements in rats: role of housing environment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Intermittent versus continuous neuroleptic treatment in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Tardive dyskinesia and substrates of energy metabolism in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The basal ganglia and adaptive motor control

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Oral dyskinesia in rats following brain lesions and neuroleptic drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

THE PHENOTHIAZINETRANQUILIZERS: BIOCHEMICAL AND BIOPHYSICAL ACTIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Effect of aging on concentrations of D2-receptor-containing neurons in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha-tocopherol in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Tardive dyskinesia--reversible and persistent

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The relationship between motor effects in rats following acute and chronic haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Drug-induced oral dyskinesias in rats after traditional and new neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Prevalence of abnormal involuntary movements ("spontaneous dyskinesias") in the normal elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The effect of chronic haloperidol treatment on dendritic spines in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Semisynthetic sphingolipids prevent protein kinase C translocation and neuronal damage in the perifocal area following a photochemically induced thrombotic brain cortical lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Haloperidol induces persistent down-regulation of tyrosine hydroxylase immunoreactivity in substantia nigra but not ventral tegmental area in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neuroleptic-induced oral movements in rats: methodological issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Bcl-2 prevents hippocampal cell death induced by the neuroleptic drug haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Intranigral stimulation of oral movements by [Pro9] substance P, a neurokinin-1 receptor agonist, is enhanced in chronically neuroleptic-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens, and medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Haloperidol-induced morphological changes in striatum are associated with glutamate synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

MRI abnormalities in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

YM-14673, a thyrotropin-releasing hormone analogue, injected into the nucleus accumbens and the striatum produces repetitive jaw movements in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Depolarization inactivation of dopamine neurons: terminal release characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenthixol) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Gangliosides. Their role in clinical neurology.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Possible genetic factors underlying the pathophysiology of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Acute dystonia induced by neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Induction of reactive oxygen species in neurons by haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Dopamine receptor pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Oxidative damage and mitochondrial decay in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Improvement in Tardive Dyskinesia After Muscimol Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

GABA agonist treatment improves tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Mitochondrial diseases in man and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Dyskinesias Evoked in Monkeys by Weekly Administration of Haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Prospective study of tardive dyskinesia in the elderly: rates and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Familial tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Gender differences in tardive dyskinesia: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under long-term administration of a neuroleptic

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

Biphasic nature of the binding of cationic amphipaths with artificial and biological membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2899%2900064-7

7 January 2021

10.1016/S0301-0082(99)00064-7

Identifiers

DOI

1 reference

29 July 2017

1 reference